PD-1 Inhibitor Plus Radiotherapy to Patients With CA19-9-elevated Advanced Pancreatic Cancer
Conditions: Pancreatic Adenocarcinoma Interventions: Drug: Gemcitabine, Nab-paclitaxel, Irinotecan; Radiation: Intensity-Modulated Radiation Therapy (IMRT); Drug: Camrelizumab Sponsors: Fudan University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Intensity-Modulated Radiation Therapy | Pancreas | Pancreatic Cancer | Radiation Therapy | Research